Section Arrow
Quote
ANIP.NASDAQ
- ANI Pharmaceuticals
Quotes are at least 15-min delayed:2026/02/09 23:54 EST
Regular Hours
Last
 80.34
-1.5 (-1.83%)
Day High 
82.05 
Prev. Close
81.84 
1-M High
87.07 
Volume 
481.63K 
Bid
32.14
Ask
91.21
Day Low
78.375 
Open
82.05 
1-M Low
75.1 
Market Cap 
1.84B 
Currency 美元 
P/E 50.21 
%Yield -- 
10-SMA 80.96 
20-SMA 82.37 
50-SMA 81.85 
52-W High 99.5 
52-W Low 54.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.60/9.24
Enterprise Value
2.45B
Balance Sheet
Book Value Per Share
22.52
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
614.38M
Operating Revenue Per Share
20.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.33-3.69-16.03%36.28PE
VTRSViatris15.56+0.98+6.72%227.2PE
BFRIBiofrontera0.8103-0.0107-1.30%0.74PE
CGCCanopy Growth Corp1.09-0.01-0.91%-- 
HLNHaleon plc10.88-0.1-0.91%23.79PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.